Biotech Turns Failed Drug Trial Into AI Win for Patients

When Verge Genomics' Alzheimer's drug failed, they did something radical: shared everything publicly to help other researchers avoid the same mistakes.

Now their new AI tool is making clinical trials work better for everyone.